Clinimix N14G30E and Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate
Determining the interaction of Clinimix N14G30E and Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: parenteral nutrition solution
Brand name: AminoProtect, Aminosyn II, Aminosyn II/Electrolytes, Aminosyn M, Aminosyn, Aminosyn-HBC, Aminosyn-PF, Aminosyn-RF, Aminosyn/Electrolytes, Clinimix E/Dextrose, Clinimix N14G30E, Clinimix N9G15E, Clinimix N9G20E, Clinimix/Dextrose, Clinisol SF, FreAmine HBC, FreAmine III, Hepatamine, NephrAmine, Plenamine, Premasol, Prosol, Synthamin 17, Travasol, TrophAmine, TrophAmine
Synonyms: Amino Acid Injection
Generic Name: efavirenz / emtricitabine / tenofovir
Brand name: Atripla
Synonyms: Efavirenz, emtricitabine, and tenofovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Clinimix N14G30E-Efavirenz, lamivudine, and tenofovir
- Clinimix N14G30E-Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate
- Clinimix N14G30E-Effaclor Duo
- Clinimix N14G30E-Effer-K
- Clinimix N14G30E-Effer-K Tablets
- Clinimix N14G30E-Effervescent Potassium
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Clinimix N9G15E
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Clinimix N9G20E
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Clinimix/Dextrose (2.75/5)
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Clinimix/Dextrose (4.25/10)
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Clinimix/Dextrose (4.25/20)
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Clinimix/Dextrose (4.25/25)